Literature DB >> 24634060

Altered regional brain volumes in elderly carriers of a risk variant for drug abuse in the dopamine D2 receptor gene (DRD2).

Florence F Roussotte1, Neda Jahanshad, Derrek P Hibar, Paul M Thompson.   

Abstract

Dopamine D2 receptors mediate the rewarding effects of many drugs of abuse. In humans, several polymorphisms in DRD2, the gene encoding these receptors, increase our genetic risk for developing addictive disorders. Here, we examined one of the most frequently studied candidate variant for addiction in DRD2 for association with brain structure. We tested whether this variant showed associations with regional brain volumes across two independent elderly cohorts, totaling 1,032 subjects. We first examined a large sample of 738 elderly participants with neuroimaging and genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI1). We hypothesized that this addiction-related polymorphism would be associated with structural brain differences in regions previously implicated in familial vulnerability for drug dependence. Then, we assessed the generalizability of our findings by testing this polymorphism in a non-overlapping replication sample of 294 elderly subjects from a continuation of the first ADNI project (ADNI2) to minimize the risk of reporting false positive results. In both cohorts, the minor allele-previously linked with increased risk for addiction-was associated with larger volumes in various brain regions implicated in reward processing. These findings suggest that neuroanatomical phenotypes associated with familial vulnerability for drug dependence may be partially mediated by DRD2 genotype.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24634060      PMCID: PMC4276548          DOI: 10.1007/s11682-014-9298-8

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  65 in total

1.  Reward-modulated motor information in identified striatum neurons.

Authors:  Yoshikazu Isomura; Takashi Takekawa; Rie Harukuni; Takashi Handa; Hidenori Aizawa; Masahiko Takada; Tomoki Fukai
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

2.  DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia.

Authors:  B R Lawford; M Barnes; C D Swagell; J P Connor; S C Burton; K Heslop; J Voisey; C P Morris; P Nyst; E P Noble; R M Young
Journal:  J Psychopharmacol       Date:  2012-10-31       Impact factor: 4.153

Review 3.  Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

Authors:  Karen D Ersche; Guy B Williams; Trevor W Robbins; Edward T Bullmore
Journal:  Curr Opin Neurobiol       Date:  2013-03-20       Impact factor: 6.627

4.  Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.

Authors:  Rudi Hwang; Takahiro Shinkai; Vincenzo De Luca; Daniel J Müller; Xingqun Ni; Fabio Macciardi; Steven Potkin; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  Distributed hippocampal patterns that discriminate reward context are associated with enhanced associative binding.

Authors:  Sasha M Wolosin; Dagmar Zeithamova; Alison R Preston
Journal:  J Exp Psychol Gen       Date:  2013-07-08

6.  DRD2 genotype-based variation of default mode network activity and of its relationship with striatal DAT binding.

Authors:  Fabio Sambataro; Leonardo Fazio; Paolo Taurisano; Barbara Gelao; Annamaria Porcelli; Marina Mancini; Lorenzo Sinibaldi; Gianluca Ursini; Rita Masellis; Grazia Caforio; Annabella Di Giorgio; Artor Niccoli-Asabella; Teresa Popolizio; Giuseppe Blasi; Alessandro Bertolino
Journal:  Schizophr Bull       Date:  2011-10-05       Impact factor: 9.306

7.  A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations.

Authors:  Florence F Roussotte; Neda Jahanshad; Derrek P Hibar; Elizabeth R Sowell; Omid Kohannim; Marina Barysheva; Narelle K Hansell; Katie L McMahon; Greig I de Zubicaray; Grant W Montgomery; Nicholas G Martin; Margaret J Wright; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Hum Brain Mapp       Date:  2013-02-21       Impact factor: 5.038

8.  Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects.

Authors:  Derrek P Hibar; Jason L Stein; April B Ryles; Omid Kohannim; Neda Jahanshad; Sarah E Medland; Narelle K Hansell; Katie L McMahon; Greig I de Zubicaray; Grant W Montgomery; Nicholas G Martin; Margaret J Wright; Andrew J Saykin; Clifford R Jack; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2013-06       Impact factor: 3.978

9.  Time-lapse mapping of cortical changes in schizophrenia with different treatments.

Authors:  Paul M Thompson; George Bartzokis; Kiralee M Hayashi; Andrea D Klunder; Po H Lu; Nancy Edwards; Michael S Hong; Michael Yu; Jennifer A Geaga; Arthur W Toga; Cecil Charles; Diana O Perkins; Joseph McEvoy; Robert M Hamer; Mauricio Tohen; Gary D Tollefson; Jeffrey A Lieberman
Journal:  Cereb Cortex       Date:  2008-10-08       Impact factor: 5.357

10.  Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence.

Authors:  Karen D Ersche; P Simon Jones; Guy B Williams; Dana G Smith; Edward T Bullmore; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2012-12-27       Impact factor: 13.382

View more
  6 in total

Review 1.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

2.  Effects of OPRM1 and DRD2 on brain structure in drug-naïve adolescents: Genetic and neural vulnerabilities to substance use.

Authors:  Giorgia Picci; Diana H Fishbein; John W VanMeter; Emma J Rose
Journal:  Psychopharmacology (Berl)       Date:  2021-11-24       Impact factor: 4.530

Review 3.  The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans.

Authors:  Kenneth Blum; Rajendra D Badgaiyan; Georgia M Dunston; David Baron; Edward J Modestino; Thomas McLaughlin; Bruce Steinberg; Mark S Gold; Marjorie C Gondré-Lewis
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

Review 4.  Dopamine and glucose, obesity, and reward deficiency syndrome.

Authors:  Kenneth Blum; Panayotis K Thanos; Mark S Gold
Journal:  Front Psychol       Date:  2014-09-17

Review 5.  Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.

Authors:  Kenneth Blum; Marcelo Febo; Thomas McLaughlin; Frans J Cronjé; David Han; S Mark Gold
Journal:  J Behav Addict       Date:  2014-08-26       Impact factor: 6.756

6.  Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.

Authors:  Pengji Yi; Zheyu Zhang; Siqi Huang; Jiahua Huang; Weijun Peng; Jingjing Yang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.